Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
influence the adaptability and evolvability of diploids and polyploids. Your profile You have a PhD in Computational Biology, Evolutionary Biology, (Bio)Engineering, Mathematics or Physics. You have expertise
-
experimental and computational candidates for this role. You will have: PhD, or in the final stages of PhD completion in cancer biology / evolutionary biology / cancer immunology / genomics or other relevant
-
to somatic alterations, identify disease-causing events, and understand how the genetic alterations affect treatment response by combining computational and experimental approaches. The Yang Lab is recruiting
-
the mechanistic model for marine bacterium NmHR (Mous et al., Science, 2022) to reveal how evolutionary distance translates into mechanistic diversity. A RUNNING START — WHAT IS ALREADY IN PLACE The most
-
Two postdoctoral positions (3-year) in Experimental Evolution of Methanogenic Microbiomes in Bioe...
performance and stability. You will work closely with modelling and reactor-focused colleagues to integrate evolutionary outcomes across scales. Your tasks will be: designing and running experimental evolution
-
, sequencing, automation, imaging, and bioprocessing. GBI will also have access to substantial compute resources that can be leveraged to further accelerate progress, including scientific compute, bioinformatics
-
oral microbial communities mediate differences in oral and systemic health using an evolutionary health framework. There will be a specific emphasis on applying advanced bioinformatics and statistical
-
Postdoctoral position in the development of an AI-based phenotyping system for high-throughput sc...
quantitative and statistical modelling approaches to biological systems (including crop genetics, host-pathogen interactions, pathogen population genetics, evolutionary biology...). The candidate will work in
-
part of the eDyNAmiC Cancer Grand Challenge. TRACERx is a UK-wide lung cancer evolution programme which started in 2014 and has to date recruited over 820 patients. It is the first longitudinal cancer